CDC COCA Call On Zika Virus - Webcast & Audio Online

Credit CDC

#10,951


Last week the CDC held a COCA Call on the Zika Virus that was not well publicized in advance, and so many clinicians were unable to attend the live broadcast. Over the weekend they've posted the audio, transcript, and even a video of the web cast on their website - along with ancillary materials - which you can now access. 

Primarily of interest to clinicians and health care providers, COCA (Clinician Outreach Communication Activity) calls are designed to ensure that practitioners have up-to-date information for their practices. 

The details of this latest presentation are presented below.

Zika Virus — What Clinicians Need to Know

= Free Continuing Education

Date:Tuesday, January 26, 2016   

Presenter(s)

Ingrid Rabe, MBChB, MMed
Medical Epidemiologist
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

Dana Meaney-Delman, MD, MPH, FACOG
Medical Officer
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Cynthia A. Moore, MD, PhD
Director
Division of Birth Defects and Developmental Disabilities
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention

Overview

Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes aegypti mosquitoes and an estimated 80% of persons infected with Zika virus are asymptomatic. Symptomatic disease is generally mild, with symptoms of fever, maculopapular rash, arthralgia, or nonpurulent conjunctivitis that typically last from several days to one week. Sporadic cases and outbreaks of Zika virus disease have occurred in countries in Africa and Southeast Asia. In 2015, the first local Zika virus transmission in the Americas was reported in Brazil and local transmission has now been in several countries or territories in the Americas. In the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has been reported and Zika virus infections have been confirmed in some infants with microcephaly. However, it is not known how many of the microcephaly cases are associated with Zika virus infection. Travelers to areas with ongoing outbreaks are at risk of becoming infected and spreading the virus to new areas, including the continental United States. During this COCA Call, participants will learn about the epidemiology and clinical manifestation of Zika virus disease and how early recognition and reporting of suspected cases can mitigate the risk of local transmission.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Describe the epidemiology, clinical manifestations, management, and prevention of Zika virus disease
• Discuss diagnostic testing for Zika virus infection and interpretation of test results
• Articulate the importance of early recognition and reporting of cases
• State the recommendations for pregnant women and possible Zika virus exposure
• Discuss evaluation of infants with microcephaly and the relationship of Zika and microcephaly

Call Materials

• Slides:View Now
• Transcript:Read Now
• Audio:Listen Now
• Webcast:Watch Now